What we do
We are the national HTA agency in Singapore. We conduct technical evaluations that inform funding decisions for health technologies, and drive their appropriate use by:
- Publishing technology guidances on the clinical effectiveness, safety, and cost-effectiveness of health technologies;
- Conducting value-based pricing negotiations with manufacturers to ensure that prices of patented health technologies are commensurate with the outcomes they deliver for patients and the Singapore health system;
- Tracking utilisation and outcomes related to funded health technologies to study the impact of funding decisions;
- Developing and implementing adoption strategies within public healthcare institutions to drive uptake of technology guidances.
II. Clinical Guidance
We develop and publish clinical guidances that provide concise, evidence-based recommendations to inform specific areas of clinical practice.
III. Healthcare Professional Education
We assist healthcare professionals to apply the best available evidence in their practice through collaborative continuing professional education.
IV. Healthcare Consumer Education
We provide information and tools for patients and caregivers to help them find out more about different medical conditions and treatment options, and to take part in shared decision-making with their clinicians about their healthcare needs.